| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 101.31B | 100.33B | 95.90B | 91.57B | 86.29B | 85.81B |
| Gross Profit | 26.15B | 25.34B | 24.58B | 22.78B | 21.80B | 22.86B |
| EBITDA | 4.71B | 4.60B | 4.12B | 3.32B | 3.64B | 3.79B |
| Net Income | 2.76B | 2.61B | 2.16B | 1.45B | 1.65B | 1.44B |
Balance Sheet | ||||||
| Total Assets | 50.78B | 50.74B | 51.18B | 48.69B | 46.32B | 43.19B |
| Cash, Cash Equivalents and Short-Term Investments | 29.00B | 27.84B | 29.15B | 27.17B | 25.50B | 22.85B |
| Total Debt | 11.35B | 9.80B | 10.62B | 11.27B | 10.84B | 8.46B |
| Total Liabilities | 33.07B | 32.65B | 35.05B | 33.98B | 32.70B | 30.73B |
| Stockholders Equity | 17.72B | 18.10B | 16.13B | 14.72B | 13.63B | 12.45B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 558.42M | 3.22B | 1.32B | 685.22M | 954.80M |
| Operating Cash Flow | 0.00 | 1.52B | 4.62B | 2.53B | 1.83B | 2.05B |
| Investing Cash Flow | 0.00 | -1.38B | -1.23B | -1.03B | -1.27B | -1.02B |
| Financing Cash Flow | 0.00 | -1.46B | -1.43B | -114.84M | 2.10B | 1.67B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥18.01B | 10.39 | ― | 3.81% | 9.96% | 252.72% | |
75 Outperform | ¥61.67B | 14.70 | ― | 2.94% | 16.32% | 23.04% | |
75 Outperform | ¥46.44B | 13.99 | ― | 2.28% | 7.30% | 60.93% | |
74 Outperform | ¥18.83B | 7.40 | ― | 3.47% | 4.22% | 27.56% | |
70 Outperform | ¥38.94B | 15.47 | ― | 2.56% | 7.41% | 22.70% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | ¥13.16B | 17.13 | ― | 0.84% | 8.44% | 17.98% |
Human Holdings Co., Ltd. reported its consolidated financial results for the six months ended September 30, 2025, showing a 3.2% increase in net sales and a significant rise in profits compared to the previous year. The company anticipates continued growth in net sales and operating profits for the full fiscal year ending March 31, 2026, although it expects a slight decline in profit attributable to owners of the parent.
The most recent analyst rating on (JP:2415) stock is a Buy with a Yen2273.00 price target. To see the full list of analyst forecasts on Human Holdings Co., Ltd. stock, see the JP:2415 Stock Forecast page.